Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhaled Medicines: Past, Present, and Future
Sandra D. Anderson, Paul J. Atkins, Per Bäckman, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 48-118
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Nebulization of extracellular vesicles: A promising small RNA delivery approach for lung diseases
Yohan Han, Yin Zhu, Hannah Youngblood, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 556-569
Open Access | Times Cited: 40
Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery
Ali Al-Jipouri, Samah Hamed Almurisi, Khater AL-Japairai, et al.
Polymers (2023) Vol. 15, Iss. 2, pp. 318-318
Open Access | Times Cited: 32
Emerging delivery approaches for targeted pulmonary fibrosis treatment
Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, et al.
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115147-115147
Open Access | Times Cited: 27
Optimization, In Vitro, and In Silico Characterization of Theophylline Inhalable Powder Using Raffinose-Amino Acid Combination as Fine Co-Spray-Dried Carriers
Petra Party, Lomass Soliman, Attila Nagy, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 466-466
Open Access | Times Cited: 1
Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery
Adam J. Plaunt, Tam L. Nguyen, Michel R. Corboz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 302-302
Open Access | Times Cited: 31
Mechanism of action of certain medicinal plants for the treatment of asthma
Kainat Usmani, S. K. Jain, Shweta Yadav
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116828-116828
Closed Access | Times Cited: 19
Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
Danni Li, Elena K. Schneider‐Futschik
Antibiotics (2023) Vol. 12, Iss. 3, pp. 484-484
Open Access | Times Cited: 18
Aerosol pulmonary immune engineering
Emma R. Sudduth, Michael Trautmann-Rodriguez, Nicole Gill, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114831-114831
Open Access | Times Cited: 18
Deposition and Clinical Impact of Inhaled Particles in the Lung
Pére Casan Clara, Francisco Rodríguez Jerez, J. Belda, et al.
Archivos de Bronconeumología (2023) Vol. 59, Iss. 6, pp. 377-382
Open Access | Times Cited: 17
Inhaled antibiotics: A promising drug delivery strategies for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens
Nazrul Islam, David W. Reid
Respiratory Medicine (2024) Vol. 227, pp. 107661-107661
Open Access | Times Cited: 8
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application
Luigino Calzetta, Clive P. Page, Maria Gabriella Matera, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1159-1220
Closed Access | Times Cited: 7
Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice
Haobo Weng, Weijuan Zou, Fangyan Tian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Insights into Inhalation Drug Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters
Liuhan Dong, Xiaomei Zhuang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4671-4671
Open Access | Times Cited: 6
Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment
Gokben Sahin, Özlem Akbal Dağıstan, Meltem Culha, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 111, Iss. 10, pp. 2652-2661
Open Access | Times Cited: 25
Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance
Heba Banat, Rita Ambrus, Ildikó Csóka
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123070-123070
Closed Access | Times Cited: 16
The (re)emergence of aerosol delivery: Treatment of pulmonary diseases and its clinical challenges
Rosy Ghanem, Raphaëlle Youf, Tanguy Haute, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 421-439
Open Access
A Comparative Study of Phenolic, Flavonoid and Antioxidant Compounds for Spath and Male Flower of Phoenix dactylifera L.: Extraction Method and Solvent Effects
Khadijeh Asadi, Roja Safaeian, Sedigheh Babaei, et al.
Deleted Journal (2025) Vol. 67, Iss. 1
Closed Access
In Vitro and In Vivo Assessment of Pharmacokinetic Profile of Peramivir in the Context of Inhalation Therapy
Liuhan Dong, Juanwen Hu, Qiannan Zhang, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 181-181
Open Access
Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models
Dewald Steyn, Anja Haasbroek‐Pheiffer, Wihan Pheiffer, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 195-195
Open Access
Impact of nebulizers on nanoparticles-based gene delivery efficiency: in vitro and in vivo comparison of jet and mesh nebulizers using branched-polyethyleneimine
Rosy Ghanem, Xavier Buin, Tanguy Haute, et al.
Drug Delivery (2025) Vol. 32, Iss. 1
Open Access
Current scenario and challenges of lipid-based nanomedicines for pulmonary drug delivery
Amol D. Gholap, Pankaj R. Khuspe, Md. Faiyazuddin, et al.
Elsevier eBooks (2025), pp. 21-47
Closed Access
Evaluating the Use of Inhaled Budesonide and Ipratropium Bromide Combination in Patients at High Risk of Acute Respiratory Distress Syndrome Development: A Randomized Controlled Trial
Hebatallah Ahmed Mohamed Moustafa, Faten H. Elbery, Ahmad Z. Al Meslamani, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 412-412
Open Access
A Technological Update on Inhalation Drug Delivery Devices
Ankaj Kumar, Ishwar Chandra, V. Rajesh, et al.
(2025), pp. 355-377
Closed Access
Navigating the Development of Dry Powder for Inhalation: A CDMO Perspective
Beatriz Noriega-Fernandes, Mariam Ibrahim, R.B. Cruz, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 434-434
Open Access
Exploring the influence of vaping on the pharmacokinetic fate of inhaled therapeutics
M.J. Adam, Martha Bain, Tazeen Ashraf, et al.
Archives of Toxicology (2025)
Open Access
Page 1 - Next Page

Scroll to top